Weekly Debrief (12/7–11)
This week's Weekly Debrief covers a number of interesting topics, including federal spending, the possibility of a government shutdown, SpaceWERX, the 2021 NDAA, and Palantir's new contract with the FDA.
"Two months into fiscal 2021, the federal government has spent nearly twice as much money as it has taken in through revenue after posting a 14th consecutive month of deficit spending."
"On Wednesday, the House passed a one-week continuing resolution that is expected to pass the Senate and be signed by President Donald Trump, pushing back the shutdown deadline. Negotiations for a longer-term deal are ongoing, with the border wall funding again a sticking point."
"The year-old Space Force will have its own rapid acquisition center to work with private sector companies to field new technology for military applications, Air Force leaders say. The new unit, dubbed SpaceWERX, will field commercial technology into Space Force’s growing tech portfolio, as the AFWERX program does for the Air Force."
"A lot of the focus on the annual Defense authorization is about the funding levels and policy changes for the Pentagon. But as anyone who has been in the federal market for at least a year knows, the National Defense Authorization Act is a catch all for legislation and provisions that matter to all agencies."
"Palantir’s push into federal health work continues. The data analytics company just picked up a new U.S. Food and Drug Administration contract which will span three years for a total of $44.4 million. The company’s shares, which have doubled in value over the last two months, are up around 20% on the news."
. . .